Media Contacts

Get in touch with the right contacts for all of our services.

View All Media Contacts »
View Media Guidelines (PDF) »

Nemours and Partners Receive $25 Million in Support of Clinical and Translational Research

Wednesday, Oct 23, 2013


Nemours/Alfred I. duPont Hospital for Children, along with Christiana Care Health System (CCHS), the University of Delaware (UD) and the Medical University of South Carolina (MUSC), has received $25 million to support the growth of clinical and translational research over the next five years. The total includes almost $20 million from the National Institutes of Health (NIH) and $5 million from the state of Delaware, with an additional $3.3 million in matching funds provided by the four participating institutions.

The new program, called Delaware-CTR ACCEL, will be led by UD's Associate Vice Provost for Clinical and Translational Research, Stuart Binder-Macleod, PhD. The program executive committee includes members from each of the participating institutions. The Nemours representative is duPont Hospital's Associate Chief of Urology, Julia S. Barthold, MD.

The NIH funding is provided via the Institutional Development Award (IDeA) program, which builds research capacity in states that historically have had low levels of NIH funding. The grant will allow the collaborators to recruit faculty in priority areas, develop programs for mentoring and faculty education, set up an epidemiology and biostatistics clearinghouse to help people design their studies and electronically track data, and engage community groups and individuals in research to improve treatment and health outcomes.

“During the first year of the grant, we will begin cross-institutional activities that include mentoring, collaborative and pilot research activities, and planning for recruitment of mid-level investigators,” said Dr. Barthold, who will devote 30 percent of her time to the Delaware-CTR ACCEL program.

Robert Akins, Jr, PhD, director of the Center for Pediatric Clinical Research and Development, will play a major role in developing a mentoring, education and faculty development resource that will benefit all participating institutions. Nemours, particularly H. Timothy Bunnell, PhD, director of the Center for Pediatric Auditory and Speech Sciences, will play an important role in establishing a working web site for scientists seeking grants and collaborators.

“This is the largest multi-institutional grant ever awarded in Delaware,” Dr. Barthold added. “The DE-CTR augments the work of the Delaware Health Sciences Alliance, which over the past four years has laid the groundwork for serious collaborative research and building the level of scientific expertise. It raises everyone’s boat by tapping into each institution’s strengths and accelerating our work on promising projects.”

The areas of focus for the CTR will include obesity, infant mortality, cancer, cardiovascular disease, rehabilitation and women’s health.

About Nemours

Nemours is an internationally recognized children's health system that owns and operates the two free-standing children’s hospitals: the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children's Hospital in Orlando, Fla., along with outpatient facilities in five states, delivering pediatric primary, specialty and urgent care. Nemours also powers the world’s most-visited website for information on the health of children and teens,, and offers on-demand, online video patient visits through Nemours CareConnect. Nemours is a program dedicated to preventing reading failure in young children, grounded in Nemours’ understanding that child health and learning are inextricably linked, and that reading level is a strong predictor of adult health.

Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours provides pediatric clinical care, research, education, advocacy and prevention programs to families in the communities it serves.